Moreover, OPG (osteoprotegerin) (RANKL [Receptor Activator for Nuclear Factor κB Ligand]/RANK [Receptor activator of nuclear factor-κB]) pathway is an important element of osteoporosis pathogenesis among patients suffering from IBD [22]. This evidence concerns the gene TNFRSF11B and inflammatory bowel disease.